Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics

被引：0
|
作者：
Gisondi, Paolo [1 ]
Bellinato, Francesco [1 ]
Idolazzi, Luca [2 ]
Zabotti, Alen [3 ,4 ]
McGonagle, Dennis [4 ,5 ]
Girolomoni, Giampiero [1 ]
机构：
[1] Univ Verona, Sect Dermatol, Verona, Italy
[2] Univ Verona, Sect Rheumatol, Verona, Italy
[3] Azienda Sanit Univ Friuli Cent, Udine, Italy
[4] NIHR Leeds Biomed Res Ctr, LTHT, Leeds, England
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
D O I：
10.1093/bjd/ljae360.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FC29
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics
    Gisondi, Paolo
    Bellinato, Francesco
    Galeone, Carlotta
    Turati, Federica
    Idolazzi, Luca
    Zabotti, Alen
    Mcgonagle, Dennis
    Girolomoni, Giampiero
    ANNALS OF THE RHEUMATIC DISEASES, 2025, 84 (03) : 435 - 441
  • [2] Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysis
    Strober, Bruce
    Soliman, Ahmed M.
    Li, Chao
    Patel, Manish
    Unigwe, Ikenna
    Gisondi, Paolo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1143 - 1149
  • [3] Risk of psoriatic arthritis in psoriasis patients on biologics and methotrexate
    Lininger, E. N.
    Siegel, S. A.
    Winthrop, K. L.
    Deodhar, A.
    Kiwalkar, S.
    Ortega-Loayza, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S63 - S63
  • [4] Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development
    Floris, Alberto
    Mugheddu, Cristina
    Sichi, Leonardo
    Anedda, Jasmine
    Frau, Alessia
    Sorgia, Jessica
    Li Volsi, Laura
    Paladino, Maria Teresa
    Congia, Mattia
    Chessa, Elisabetta
    Angioni, Maria Maddalena
    Naitza, Micaela
    Ferreli, Caterina
    Piga, Matteo
    Atzori, Laura
    Cauli, Alberto
    RHEUMATOLOGY, 2024,
  • [5] BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS
    Dotan, A.
    Ben-Shabat, N.
    Mcgonagle, D.
    Amital, H.
    Watad, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1148 - 1149
  • [6] Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
    Gisondi, Paolo
    Bellinato, Francesco
    Maurelli, Martina
    Geat, Davide
    Zabotti, Alen
    McGonagle, Dennis
    Girolomoni, Giampiero
    PSORIASIS-TARGETS AND THERAPY, 2022, 12 : 213 - 220
  • [7] Psoriasis and psoriatic arthritis: risk of infection with biologics and apremilast
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (06)
  • [8] Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis
    Singla, Shikha
    Putman, Michael
    Liew, Jean
    Gordon, Kenneth
    LANCET RHEUMATOLOGY, 2023, 5 (06): : E312 - E313
  • [9] Psoriasis and Psoriatic Arthritis: Infection Risk under Biologics and Apremilast
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2023, 48 (02) : 114 - 114
  • [10] New biologics for psoriasis and psoriatic arthritis
    Rozenblit, Mariya
    Lebwohl, Mark
    DERMATOLOGIC THERAPY, 2009, 22 (01) : 56 - 60
12345